Anaesthesia for an adult with Angelman syndrome

Anaesthesia

Volumn 64, Issue 11, 2009, Pages 1250-1253

  Maguire, Marc ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; FENTANYL; FOLIC ACID; GLYCOPYRRONIUM BROMIDE; KETAMINE; LAMOTRIGINE; MEDROXYPROGESTERONE ACETATE; NEOSTIGMINE; SEVOFLURANE; VALPROIC ACID;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CASE REPORT; CHROMOSOME DELETION; CLINICAL FEATURE; DENTISTRY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENERAL ANESTHESIA; HAPPY PUPPET SYNDROME; HUMAN; MUSCLE HYPERTONIA; PHYSICAL EXAMINATION; RESPIRATORY TRACT DISEASE; SEIZURE;

ADULT; ANESTHESIA, GENERAL; ANGELMAN SYNDROME; DENTAL CARE; FEMALE; HUMANS; MUSCLE HYPERTONIA; RESPIRATORY INSUFFICIENCY;

EID: 70350507996     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2009.06033.x     Document Type: Article

References (28)

1. Angelman H. 'Puppet' children. A report on three cases. Developmental Medicine & Child Neurology 1965; 7: 681-688
2. Williams CA, Beaudet AL, Clayton-Smith J, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. American Journal of Medical Genetics Part A 2006; 140: 413-418
3. Buckley RD, Dinno N, Weber P. Angelman syndrome: are the estimates too low? American Journal of Medical Genetics 1998; 80: 385-390
4. Bujok G, Knapik P. Angelman syndrome as a rare anaesthetic problem. Paediatric Anaesthesia 2004; 14: 281-283 (Pubitemid 38373070)
5. Clayton-Smith J, Laan L. Angelman syndrome: a review of the clinical and genetic aspects. Journal of Medical Genetics 2003; 40: 87-95. (Pubitemid 36232812)
6. Gardner JC, Turner CS, Ririe DG. Vagal hypertonia and anesthesia in Angelman syndrome. Paediatric Anaesthesia 2008; 18: 348-349
7. Pembrey M, Fennell SJ, van den Berghe J, et al. The association of Angelman's syndrome with deletions within 15q11-13. Journal of Medical Genetics 1989; 26: 73-77 (Pubitemid 19047354)
8. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nature Genetics 1997; 15: 70-73 (Pubitemid 27014952)
9. Jiang Y, Lev-Lehman E, Bressler J, Tsai TF, Beaudet AL. Genetics of Angelman syndrome. American Journal of Human Genetics 1999; 65: 1-6.
10. Pickart CM. Back to the future with ubiquitin. Cell 2004; 116: 181-190
11. Ramanathan KR, Muthuswamy D, Jenkins BJ. Anaesthesia for Angelman syndrome. Anaesthesia 2008; 63: 659-661
12. Errando CL, Murcia M, Gimeno A, Herrera R. Anesthesia in a patient with Angelman syndrome. Revista Espanola de Anestesiologia y Reanimacion 2007; 54: 566-569
13. Errando CL. Comments on a case report of Angelman syndrome anaesthesia. Anaesthesia 2008; 63: 1145-1146
14. Douchin S, Do-Ngoc D, Rossignol AM, Lucet V, Joannard A, Jouk PS. Angelman syndrome and severe vagal hypertonia. Three pediatric case reports. Archives des Maladies du Coeur et des Vaisseaux 2000; 93: 559-563
15. Vanagt WY, Pulles-Heintzberger CF, Vernooy K, Cornelussen RN, Delhaas T. Asystole during outbursts of laughing in a child with Angelman syndrome. Pediatric Cardiology 2005; 26: 866-868 (Pubitemid 43130192)
16. Bottani A, Robinson WP, DeLozier-Blanchet CD, et al. Angelman syndrome due to paternal uniparental disomy of chromosome 15: A milder phenotype? American Journal of Medical Genetics 1994; 51: 35-40.
17. Varela MC, Kok F, Otto PA, Koiffmann CP. Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects. European Journal of Human Genetics 2004; 12: 987-992 (Pubitemid 39600125)
18. Moncla A, Malzac P, Voelckel MA, et al. Phenotype-genotype correlation in 20 deletion and 20 non-deletion Angelman syndrome patients. European Journal of Human Genetics 1999; 7: 131-139 (Pubitemid 29150223)
19. Berge TMD, Minassian A, Olsen RW, et al. Angelman syndrome: correlations between epilepsy phenotypes and genotypes. Annals of Neurology 1998; 43: 485-493 (Pubitemid 28231724)
20. Lossie AC, Whitney MM, Amidon D, et al. Distinct phenotypes distinguish the molecular classes of Angelman syndrome. Journal of Medical Genetics 2001; 38: 834-845 (Pubitemid 34014208)
21. Dan B, Boyd SG. Angelman syndrome reviewed from a neurophysiological perspective. The UBE3A-GABRB3 hypothesis. Neuropediatrics 2003; 34: 169-176
22. Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. New England Journal of Medicine 2003; 348: 2110-2124
23. Jurd R, Arras M, Lambert S, et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. FASEB Journal 2003; 17: 250-252
24. Quinlan JJ, Homanics GE, Firestone LL. Anesthesia sensitivity in mice that lack the beta3 subunit of the gamma-aminobutyric acid type A receptor. Anesthesiology 1998; 88: 775-780
25. A receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. Journal of Neuroscience 1998; 18: 8505-8514
26. Homanics GE, DeLorey TM, Firestone LL, et al. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 4143-4148
27. Holopainen IE, Metsahonkala EL, Kokkonen H, et al. Decreased binding of [11C]flumazenil in Angelman syndrome patients with GABA(A) receptor beta3 subunit deletions. Annals of Neurology 2001; 49: 110-113
28. Odano I, Anezaki T, Ohkubo M, et al. Decrease in benzodiazepine receptor binding in a patient with Angelman syndrome detected by iodine-123 iomazenil and single-photon emission tomography. European Journal of Nuclear Medicine 1996; 23: 598-604. (Pubitemid 26140594)